世界の経皮ニコチンパッチ市場2021-2026:7mg / 24時間、14mg / 24時間、21mg / 24時間、10mg / 16時間、15mg / 16時間、25mg / 16時間

LP Informationが発行した調査報告書(LPI21MY9676)
◆英語タイトル:Global Transdermal Nicotine Patch Market Growth 2021-2026
◆商品コード:LPI21MY9676
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:131
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「経皮ニコチンパッチの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、7mg / 24時間、14mg / 24時間、21mg / 24時間、10mg / 16時間、15mg / 16時間、25mg / 16時間など、用途別には、離脱クリニック、医療行為、個人喫煙者、その他などにセグメント区分してまとめました。経皮ニコチンパッチのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・経皮ニコチンパッチの世界市場概要(サマリー)
・経皮ニコチンパッチの企業別販売量・売上
・経皮ニコチンパッチの企業別市場シェア
・経皮ニコチンパッチの世界市場規模 2016年-2021年:種類別(7mg / 24時間、14mg / 24時間、21mg / 24時間、10mg / 16時間、15mg / 16時間、25mg / 16時間)
・経皮ニコチンパッチの世界市場規模 2016年-2021年:用途別(離脱クリニック、医療行為、個人喫煙者、その他)
・経皮ニコチンパッチの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・経皮ニコチンパッチのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・経皮ニコチンパッチのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・経皮ニコチンパッチの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・経皮ニコチンパッチ市場の成長要因・課題・動向
・経皮ニコチンパッチの世界市場予測 2021年-2026年
・経皮ニコチンパッチの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・経皮ニコチンパッチのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・経皮ニコチンパッチのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・経皮ニコチンパッチの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・経皮ニコチンパッチの世界市場予測:種類別(7mg / 24時間、14mg / 24時間、21mg / 24時間、10mg / 16時間、15mg / 16時間、25mg / 16時間)
・経皮ニコチンパッチの世界市場予測:用途別(離脱クリニック、医療行為、個人喫煙者、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Transdermal Nicotine Patch will have significant change from previous year. By the most conservative estimates of global Transdermal Nicotine Patch market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Transdermal Nicotine Patch market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Nicotine Patch market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
7mg/24hrs
14mg/24hrs
21mg/24hrs
10mg/16hrs
15mg/16hrs
25mg/16hrs

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Withdrawal Clinics
Medical Practice
Individual Smokers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GlaxoSmithKline
Novartis
Johnson & Johnson
Perrigo Company
Mylan
Dr. Reddy’s Laboratories
Rusan Pharma

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Nicotine Patch Consumption 2016-2026
2.1.2 Transdermal Nicotine Patch Consumption CAGR by Region
2.2 Transdermal Nicotine Patch Segment by Type
2.2.1 7mg/24hrs
2.2.2 14mg/24hrs
2.2.3 21mg/24hrs
2.2.4 10mg/16hrs
2.2.5 15mg/16hrs
2.2.6 25mg/16hrs
2.3 Transdermal Nicotine Patch Sales by Type
2.3.1 Global Transdermal Nicotine Patch Sales Market Share by Type (2016-2021)
2.3.2 Global Transdermal Nicotine Patch Revenue and Market Share by Type (2016-2021)
2.3.3 Global Transdermal Nicotine Patch Sale Price by Type (2016-2021)
2.4 Transdermal Nicotine Patch Segment by Application
2.4.1 Withdrawal Clinics
2.4.2 Medical Practice
2.4.3 Individual Smokers
2.4.4 Others
2.5 Transdermal Nicotine Patch Sales by Application
2.5.1 Global Transdermal Nicotine Patch Sale Market Share by Application (2016-2021)
2.5.2 Global Transdermal Nicotine Patch Revenue and Market Share by Application (2016-2021)
2.5.3 Global Transdermal Nicotine Patch Sale Price by Application (2016-2021)

3 Global Transdermal Nicotine Patch by Company
3.1 Global Transdermal Nicotine Patch Sales Market Share by Company
3.1.1 Global Transdermal Nicotine Patch Sales by Company (2019-2021)
3.1.2 Global Transdermal Nicotine Patch Sales Market Share by Company (2019-2021)
3.2 Global Transdermal Nicotine Patch Revenue Market Share by Company
3.2.1 Global Transdermal Nicotine Patch Revenue by Company (2019-2021)
3.2.2 Global Transdermal Nicotine Patch Revenue Market Share by Company (2019-2021)
3.3 Global Transdermal Nicotine Patch Sale Price by Company
3.4 Global Manufacturers Transdermal Nicotine Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transdermal Nicotine Patch Product Location Distribution
3.4.2 Players Transdermal Nicotine Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Transdermal Nicotine Patch by Region
4.1 Global Transdermal Nicotine Patch by Region
4.1.1 Global Transdermal Nicotine Patch Sales by Region
4.1.2 Global Transdermal Nicotine Patch Revenue by Region
4.2 Americas Transdermal Nicotine Patch Sales Growth
4.3 APAC Transdermal Nicotine Patch Sales Growth
4.4 Europe Transdermal Nicotine Patch Sales Growth
4.5 Middle East & Africa Transdermal Nicotine Patch Sales Growth

5 Americas
5.1 Americas Transdermal Nicotine Patch Sales by Country
5.1.1 Americas Transdermal Nicotine Patch Sales by Country (2016-2021)
5.1.2 Americas Transdermal Nicotine Patch Revenue by Country (2016-2021)
5.2 Americas Transdermal Nicotine Patch Sales by Type
5.3 Americas Transdermal Nicotine Patch Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Transdermal Nicotine Patch Sales by Region
6.1.1 APAC Transdermal Nicotine Patch Sales by Region (2016-2021)
6.1.2 APAC Transdermal Nicotine Patch Revenue by Region (2016-2021)
6.2 APAC Transdermal Nicotine Patch Sales by Type
6.3 APAC Transdermal Nicotine Patch Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Transdermal Nicotine Patch by Country
7.1.1 Europe Transdermal Nicotine Patch Sales by Country (2016-2021)
7.1.2 Europe Transdermal Nicotine Patch Revenue by Country (2016-2021)
7.2 Europe Transdermal Nicotine Patch Sales by Type
7.3 Europe Transdermal Nicotine Patch Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Transdermal Nicotine Patch by Country
8.1.1 Middle East & Africa Transdermal Nicotine Patch Sales by Country (2016-2021)
8.1.2 Middle East & Africa Transdermal Nicotine Patch Revenue by Country (2016-2021)
8.2 Middle East & Africa Transdermal Nicotine Patch Sales by Type
8.3 Middle East & Africa Transdermal Nicotine Patch Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Transdermal Nicotine Patch Distributors
10.3 Transdermal Nicotine Patch Customer

11 Global Transdermal Nicotine Patch Market Forecast
11.1 Global Transdermal Nicotine Patch Forecast by Region
11.1.1 Global Transdermal Nicotine Patch Forecast by Regions (2021-2026)
11.2.2 Global Transdermal Nicotine Patch Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Transdermal Nicotine Patch Forecast by Type
11.7 Global Transdermal Nicotine Patch Forecast by Application

12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline GlaxoSmithKline Company Information
12.1.2 GlaxoSmithKline Transdermal Nicotine Patch Product Offered
12.1.3 GlaxoSmithKline Transdermal Nicotine Patch Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GlaxoSmithKline Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis Transdermal Nicotine Patch Product Offered
12.2.3 Novartis Transdermal Nicotine Patch Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Information
12.3.2 Johnson & Johnson Transdermal Nicotine Patch Product Offered
12.3.3 Johnson & Johnson Transdermal Nicotine Patch Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Johnson & Johnson Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Perrigo Company
12.4.1 Perrigo Company Company Information
12.4.2 Perrigo Company Transdermal Nicotine Patch Product Offered
12.4.3 Perrigo Company Transdermal Nicotine Patch Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Perrigo Company Main Business Overview
12.4.5 Perrigo Company Latest Developments
12.5 Mylan
12.5.1 Mylan Company Information
12.5.2 Mylan Transdermal Nicotine Patch Product Offered
12.5.3 Mylan Transdermal Nicotine Patch Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Mylan Main Business Overview
12.5.5 Mylan Latest Developments
12.6 Dr. Reddy’s Laboratories
12.6.1 Dr. Reddy’s Laboratories Company Information
12.6.2 Dr. Reddy’s Laboratories Transdermal Nicotine Patch Product Offered
12.6.3 Dr. Reddy’s Laboratories Transdermal Nicotine Patch Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Dr. Reddy’s Laboratories Main Business Overview
12.6.5 Dr. Reddy’s Laboratories Latest Developments
12.7 Rusan Pharma
12.7.1 Rusan Pharma Company Information
12.7.2 Rusan Pharma Transdermal Nicotine Patch Product Offered
12.7.3 Rusan Pharma Transdermal Nicotine Patch Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Rusan Pharma Main Business Overview
12.7.5 Rusan Pharma Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Transdermal Nicotine Patch Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 7mg/24hrs
Table 3. Major Players of 14mg/24hrs
Table 4. Major Players of 21mg/24hrs
Table 5. Major Players of 10mg/16hrs
Table 6. Major Players of 15mg/16hrs
Table 7. Major Players of 25mg/16hrs
Table 8. Global Transdermal Nicotine Patch Sales by Type (2016-2021) & (K Units)
Table 9. Global Transdermal Nicotine Patch Sales Market Share by Type (2016-2021)
Table 10. Global Transdermal Nicotine Patch Revenue by Type (2016-2021) & ($ million)
Table 11. Global Transdermal Nicotine Patch Revenue Market Share by Type (2016-2021)
Table 12. Global Transdermal Nicotine Patch Sale Price by Type (2016-2021)
Table 13. Global Transdermal Nicotine Patch Sales by Application (2016-2021) & (K Units)
Table 14. Global Transdermal Nicotine Patch Sales Market Share by Application (2016-2021)
Table 15. Global Transdermal Nicotine Patch Value by Application (2016-2021)
Table 16. Global Transdermal Nicotine Patch Revenue Market Share by Application (2016-2021)
Table 17. Global Transdermal Nicotine Patch Sale Price by Application (2016-2021)
Table 18. Global Transdermal Nicotine Patch Sales by Company (2019-2021) & (K Units)
Table 19. Global Transdermal Nicotine Patch Sales Market Share by Company (2019-2021)
Table 20. Global Transdermal Nicotine Patch Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Transdermal Nicotine Patch Revenue Market Share by Company (2019-2021)
Table 22. Global Transdermal Nicotine Patch Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Transdermal Nicotine Patch Producing Area Distribution and Sales Area
Table 24. Players Transdermal Nicotine Patch Products Offered
Table 25. Transdermal Nicotine Patch Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Transdermal Nicotine Patch Sales by Region (2016-2021) (K Units)
Table 29. Global Transdermal Nicotine Patch Sales Market Share by Region (2016-2021)
Table 30. Global Transdermal Nicotine Patch Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Transdermal Nicotine Patch Revenue Market Share by Region (2016-2021)
Table 32. Americas Transdermal Nicotine Patch Sales by Country (2016-2021) & (K Units)
Table 33. Americas Transdermal Nicotine Patch Sales Market Share by Country (2016-2021)
Table 34. Americas Transdermal Nicotine Patch Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Transdermal Nicotine Patch Revenue Market Share by Country (2016-2021)
Table 36. Americas Transdermal Nicotine Patch Sales by Type (2016-2021) & (K Units)
Table 37. Americas Transdermal Nicotine Patch Sales Market Share by Type (2016-2021)
Table 38. Americas Transdermal Nicotine Patch Sales by Application (2016-2021) & (K Units)
Table 39. Americas Transdermal Nicotine Patch Sales Market Share by Application (2016-2021)
Table 40. APAC Transdermal Nicotine Patch Sales by Region (2016-2021) & (K Units)
Table 41. APAC Transdermal Nicotine Patch Sales Market Share by Region (2016-2021)
Table 42. APAC Transdermal Nicotine Patch Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Transdermal Nicotine Patch Revenue Market Share by Region (2016-2021)
Table 44. APAC Transdermal Nicotine Patch Sales by Type (2016-2021) & (K Units)
Table 45. APAC Transdermal Nicotine Patch Sales Market Share by Type (2016-2021)
Table 46. APAC Transdermal Nicotine Patch Sales by Application (2016-2021) & (K Units)
Table 47. APAC Transdermal Nicotine Patch Sales Market Share by Application (2016-2021)
Table 48. Europe Transdermal Nicotine Patch Sales by Country (2016-2021) & (K Units)
Table 49. Europe Transdermal Nicotine Patch Sales Market Share by Country (2016-2021)
Table 50. Europe Transdermal Nicotine Patch Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Transdermal Nicotine Patch Revenue Market Share by Country (2016-2021)
Table 52. Europe Transdermal Nicotine Patch Sales by Type (2016-2021) & (K Units)
Table 53. Europe Transdermal Nicotine Patch Sales Market Share by Type (2016-2021)
Table 54. Europe Transdermal Nicotine Patch Sales by Application (2016-2021) & (K Units)
Table 55. Europe Transdermal Nicotine Patch Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Transdermal Nicotine Patch Sales by Country (2016-2021) & (K Units)
Table 57. Middle East & Africa Transdermal Nicotine Patch Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Transdermal Nicotine Patch Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Transdermal Nicotine Patch Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Transdermal Nicotine Patch Sales by Type (2016-2021) & (K Units)
Table 61. Middle East & Africa Transdermal Nicotine Patch Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Transdermal Nicotine Patch Sales by Application (2016-2021) & (K Units)
Table 63. Middle East & Africa Transdermal Nicotine Patch Sales Market Share by Application (2016-2021)
Table 64. Global Transdermal Nicotine Patch Sales Forecast by Type (2021-2026) & (K Units)
Table 65. Global Transdermal Nicotine Patch Sales Market Share Forecast by Type (2021-2026)
Table 66. Global Transdermal Nicotine Patch Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 67. Global Transdermal Nicotine Patch Revenue Market Share Forecast by Type (2021-2026)
Table 68. Global Transdermal Nicotine Patch Sales Forecast by Application (2021-2026) & (K Units)
Table 69. Global Transdermal Nicotine Patch Sales Market Share Forecast by Application (2021-2026)
Table 70. Global Transdermal Nicotine Patch Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 71. Global Transdermal Nicotine Patch Revenue Market Share Forecast by Application (2021-2026)
Table 72. GlaxoSmithKline Basic Information, Transdermal Nicotine Patch Manufacturing Base, Sales Area and Its Competitors
Table 73. GlaxoSmithKline Transdermal Nicotine Patch Product Offered
Table 74. GlaxoSmithKline Transdermal Nicotine Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Latest Developments
Table 77. Novartis Basic Information, Transdermal Nicotine Patch Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis Transdermal Nicotine Patch Product Offered
Table 79. Novartis Transdermal Nicotine Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Johnson & Johnson Basic Information, Transdermal Nicotine Patch Manufacturing Base, Sales Area and Its Competitors
Table 83. Johnson & Johnson Transdermal Nicotine Patch Product Offered
Table 84. Johnson & Johnson Transdermal Nicotine Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 85. Johnson & Johnson Main Business
Table 86. Johnson & Johnson Latest Developments
Table 87. Perrigo Company Basic Information, Transdermal Nicotine Patch Manufacturing Base, Sales Area and Its Competitors
Table 88. Perrigo Company Transdermal Nicotine Patch Product Offered
Table 89. Perrigo Company Transdermal Nicotine Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 90. Perrigo Company Main Business
Table 91. Perrigo Company Latest Developments
Table 92. Mylan Basic Information, Transdermal Nicotine Patch Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Transdermal Nicotine Patch Product Offered
Table 94. Mylan Transdermal Nicotine Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 95. Mylan Main Business
Table 96. Mylan Latest Developments
Table 97. Dr. Reddy's Laboratories Basic Information, Transdermal Nicotine Patch Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr. Reddy's Laboratories Transdermal Nicotine Patch Product Offered
Table 99. Dr. Reddy's Laboratories Transdermal Nicotine Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 100. Dr. Reddy's Laboratories Main Business
Table 101. Dr. Reddy's Laboratories Latest Developments
Table 102. Rusan Pharma Basic Information, Transdermal Nicotine Patch Manufacturing Base, Sales Area and Its Competitors
Table 103. Rusan Pharma Transdermal Nicotine Patch Product Offered
Table 104. Rusan Pharma Transdermal Nicotine Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 105. Rusan Pharma Main Business
Table 106. Rusan Pharma Latest Developments
List of Figures
Figure 1. Picture of Transdermal Nicotine Patch
Figure 2. Transdermal Nicotine Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transdermal Nicotine Patch Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Transdermal Nicotine Patch Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Transdermal Nicotine Patch Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 7mg/24hrs
Figure 10. Product Picture of 14mg/24hrs
Figure 11. Product Picture of 21mg/24hrs
Figure 12. Product Picture of 10mg/16hrs
Figure 13. Product Picture of 15mg/16hrs
Figure 14. Product Picture of 25mg/16hrs
Figure 15. Global Transdermal Nicotine Patch Sales Market Share by Type in 2020
Figure 16. Global Transdermal Nicotine Patch Revenue Market Share by Type (2016-2021)
Figure 17. Transdermal Nicotine Patch Consumed in Withdrawal Clinics
Figure 18. Global Transdermal Nicotine Patch Market: Withdrawal Clinics (2016-2021) & (K Units)
Figure 19. Transdermal Nicotine Patch Consumed in Medical Practice
Figure 20. Global Transdermal Nicotine Patch Market: Medical Practice (2016-2021) & (K Units)
Figure 21. Transdermal Nicotine Patch Consumed in Individual Smokers
Figure 22. Global Transdermal Nicotine Patch Market: Individual Smokers (2016-2021) & (K Units)
Figure 23. Transdermal Nicotine Patch Consumed in Others
Figure 24. Global Transdermal Nicotine Patch Market: Others (2016-2021) & (K Units)
Figure 25. Global Transdermal Nicotine Patch Sales Market Share by Application (2016-2021)
Figure 26. Global Transdermal Nicotine Patch Revenue Market Share by Application in 2020
Figure 27. Global Transdermal Nicotine Patch Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Transdermal Nicotine Patch Revenue Market Share by Company in 2020
Figure 29. Global Transdermal Nicotine Patch Sales Market Share by Regions (2016-2021)
Figure 30. Global Transdermal Nicotine Patch Revenue Market Share by Region in 2020
Figure 31. Americas Transdermal Nicotine Patch Sales 2016-2021 (K Units)
Figure 32. Americas Transdermal Nicotine Patch Revenue 2016-2021 ($ Millions)
Figure 33. APAC Transdermal Nicotine Patch Sales 2016-2021 (K Units)
Figure 34. APAC Transdermal Nicotine Patch Revenue 2016-2021 ($ Millions)
Figure 35. Europe Transdermal Nicotine Patch Sales 2016-2021 (K Units)
Figure 36. Europe Transdermal Nicotine Patch Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Transdermal Nicotine Patch Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa Transdermal Nicotine Patch Revenue 2016-2021 ($ Millions)
Figure 39. Americas Transdermal Nicotine Patch Sales Market Share by Country in 2020
Figure 40. Americas Transdermal Nicotine Patch Revenue Market Share by Country in 2020
Figure 41. Americas Transdermal Nicotine Patch Sales Market Share by Type in 2020
Figure 42. Americas Transdermal Nicotine Patch Sales Market Share by Application in 2020
Figure 43. United States Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Transdermal Nicotine Patch Sales Market Share by Region in 2020
Figure 48. APAC Transdermal Nicotine Patch Revenue Market Share by Regions in 2020
Figure 49. APAC Transdermal Nicotine Patch Sales Market Share by Type in 2020
Figure 50. APAC Transdermal Nicotine Patch Sales Market Share by Application in 2020
Figure 51. China Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Transdermal Nicotine Patch Sales Market Share by Country in 2020
Figure 58. Europe Transdermal Nicotine Patch Revenue Market Share by Country in 2020
Figure 59. Europe Transdermal Nicotine Patch Sales Market Share by Type in 2020
Figure 60. Europe Transdermal Nicotine Patch Sales Market Share by Application in 2020
Figure 61. Germany Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Transdermal Nicotine Patch Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Transdermal Nicotine Patch Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Transdermal Nicotine Patch Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Transdermal Nicotine Patch Sales Market Share by Application in 2020
Figure 70. Egypt Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Transdermal Nicotine Patch Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の経皮ニコチンパッチ市場2021-2026:7mg / 24時間、14mg / 24時間、21mg / 24時間、10mg / 16時間、15mg / 16時間、25mg / 16時間(Global Transdermal Nicotine Patch Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。